#16USNYSE

CON

Concentra Group Holdings Parent, Inc.

$37.54USD

Data as of 2026-10-14

Composite Score71.0Exceptional

−16

Margin of safety−16%Overvalued

Fair value$32.25

Target$54.73

Loss chance35%Moderate-low

SizeMid cap

SectorHealth Care

Dividend0.67%

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Health Care median (n=163)

Quality
Profit margins & asset efficiency
82
Exceptional
Health Care median (n=163) 51
Value
Price vs fundamentals
65
Strong
Health Care median (n=163) 52
Growth
Revenue & earnings trajectory
60
Strong
Health Care median (n=163) 50
Momentum
Recent price strength
93
Exceptional
Health Care median (n=163) 66
Health
Balance sheet & solvency
45
Average
Health Care median (n=163) 56
Profitability
ROE, ROA, ROIC
59
Strong
Health Care median (n=163) 49
Technical
Trend & volatility signals
63
Strong
Health Care median (n=163) 57
Risk
Volatility & drawdown profile
88
Exceptional
Health Care median (n=163) 47

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Fair price check

4 different valuation methods each estimate what CON should be worth, then we compare to today's price.

Looks overvalued

Models suggest CON is trading above fair value

Today's price

$37.54

Median fair price

$32.25

-14% vs today's price

Of 4 methods:1 say cheap1 say fair2 say pricey

EV/EBITDAUndervalued
thinks it's a bargain — estimates $54.73, about 46% above today
P/E multiplesFair
thinks it's fairly priced — estimates $42.61, about 13% above today
DCF (2-stage)Overvalued
thinks it's expensive — estimates $21.89, about 42% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $12.94, about 66% below today

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $32.25
Margin of safety(vs fair value): -16.4%
Max (ex-outliers): $54.73
Tangible BVPS: —

Median of all applicable methods (current price $37.54). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$4.79B
Revenue (TTM)	$2.29B
Net income (TTM)	$205.60M
Operating cash flow (TTM)	$335.55M
CapEx (TTM)	$68.13M
Free cash flow (TTM)CFO − CapEx	$267.42M
Total assets	$3.01B
Total liabilities	$2.50B
Stockholders' equity	$477.10M
Cash & equivalents	$158.04M
Shares outstanding	127.52M
EPS (basic)	$1.61
EPS (diluted)	$1.61
P/E ratio (TTM)	23.28

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-08-06
Latest period end: 2026-07-31
Filing lag: 69 days
Missing metrics: 7(gross_profit, cost_of_revenue, research_and_development, interest_expense, inventory, long_term_debt, short_term_debt)